Response Genetics Inc (RGDXQ) SEC Filing 8-K Material Event for the period ending Thursday, July 2, 2015

Response Genetics Inc

CIK: 1124608 Ticker: RGDXQ

View differences made from one to another to evaluate Response Genetics Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Response Genetics Inc.


Assess how Response Genetics Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Response Genetics Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2015 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


Ticker: RGDXQ
CIK: 1124608
Form Type: 8-K Corporate News
Accession Number: 0001144204-15-041012
Submitted to the SEC: Mon Jul 06 2015 7:00:15 AM EST
Accepted by the SEC: Mon Jul 06 2015
Period: Thursday, July 2, 2015
Industry: In Vitro And In Vivo Diagnostic Substances
  1. Listing Status

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: